REFERENCES
1. Müller J, Szűcs-Farkas D, Szegedi I, Csóka M, Garami M, Tiszlavicz LG, et al. Clinical Course of COVID-19 Disease in Children Treated With Neoplastic Diseases in Hungary. Pathol Oncol Res. 2022;28:1610261.
2. Mukkada S, Bhakta N, Chantada GL, Chen Y, Vedaraju Y, Faughnan L, et al. Global characteristics and outcomes of SARS-CoV-2 infection in children and adolescents with cancer (GRCCC): a cohort study. Lancet Oncol. 2021 Oct;22(10):1416–26.
3. WHO Coronavirus (COVID-19) Dashboard [Internet]. [cited 2023 Apr 23]. Available from: https://covid19.who.int
4. Kahn AR, Schwalm CM, Wolfson JA, Levine JM, Johnston EE. COVID-19 in Children with Cancer. Curr Oncol Rep. 2022 Mar 1;24(3):295–302.
5. Ljungman P, de la Camara R, Mikulska M, Tridello G, Aguado B, Zahrani MA, et al. COVID-19 and stem cell transplantation; results from an EBMT and GETH multicenter prospective survey. Leukemia. 2021 Oct;35(10):2885–94.
6. Bhatt NS, Sharma A, St Martin A, Abid MB, Brown VI, Diaz Perez MA, et al. Clinical Characteristics and Outcomes of COVID-19 in Pediatric and Early Adolescent and Young Adult Hematopoietic Stem Cell Transplant Recipients: A Cohort Study. Transplant Cell Ther. 2022 Oct;28(10):696.e1-696.e7.
7. Schlage S, Lehrnbecher T, Berner R, Simon A, Toepfner N. SARS-CoV-2 in pediatric cancer: a systematic review. Eur J Pediatr. 2022 Apr 1;181(4):1413–27.
8. Averbuch D, de la Camara R, Tridello G, Knelange NS, Bykova TA, Ifversen M, et al. Risk factors for a severe disease course in children with SARS-COV-2 infection following hematopoietic cell transplantation in the pre-Omicron period: a prospective multinational Infectious Disease Working Party from the European Society for Blood and Marrow Transplantation group (EBMT) and the Spanish Group of Hematopoietic Stem Cell Transplantation (GETH) study. Bone Marrow Transplant. 2023 May;58(5):558–66.
9. El-Qushayri AE, Benmelouka AY, Dahy A, Hashan MR. COVID-19 outcomes in paediatric cancer: A large scale pooled meta-analysis of 984 cancer patients. Reviews in Medical Virology. 2022;32(5):e2344.
10. SEHOP 2021: Inicio [Internet]. [cited 2023 Sep 26]. Available from: https://www.geyseco.es/sehop2021/www.geyseco.es/sehop2021
11. XIV Congreso Nacional de la Sociedad Española de Hematología y Oncología Pediátricas: Inicio [Internet]. [cited 2023 Sep 26]. Available from: https://www.geyseco.es/sehop2022/www.geyseco.es/sehop2022
12. Latella A, Gómez S, Palladino M, Navia M, Mangano A, Borgnia D, et al. COVID-19 in Pediatric Cancer Patients and Hematopoietic Stem Cell Transplant Recipients in a Tertiary Care Hospital in Argentina. J Pediatr Hematol Oncol. 2023 Aug 1;45(6):e671–7.
13. Faura A, Rives S, Lassaletta Á, Sebastián E, Madero L, Huerta J, et al. Initial report on Spanish pediatric oncologic, hematologic, and post stem cell transplantation patients during SARS-CoV-2 pandemic. Pediatr Blood Cancer. 2020 Sep;67(9):e28557.
14. Ilinca AP, Dakhallah N, Souza AM, Leclerc M, Mezziani S, Brossard J, et al. Update: Clinical characteristics and outcomes of SARS‐CoV‐2 infection in pediatric oncology patients in the province of Quebec. Pediatr Blood Cancer. 2022 Aug 21;e29936.
15. Pagano L, Salmanton-García J, Marchesi F, Blennow O, Gomes da Silva M, Glenthøj A, et al. Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from the EPICOVIDEHA survey. Blood. 2022 Dec 29;140(26):2773–87.
16. Salmanton-García J, Marchesi F, Glenthøj A, Bilgin YM, van Praet J, Dávila-Valls J, et al. Improved Clinical Outcome of COVID-19 in Hematologic Malignancy Patients Receiving a Fourth Dose of Anti-SARS-CoV-2 Vaccine: An EPICOVIDEHA Report. Hemasphere. 2022 Nov;6(11):e789.
17. Parambil BC, Moulik NR, Dhamne C, Dhariwal N, Narula G, Vora T, et al. COVID-19 in Children with Cancer and Continuation of Cancer-Directed Therapy During the Infection. Indian J Pediatr. 2022 May 1;89(5):445–51.
18. Millen GC, Arnold R, Cazier JB, Curley H, Feltbower R, Gamble A, et al. COVID-19 in children with haematological malignancies. Arch Dis Child. 2022 Feb;107(2):186–8.
19. Zama D, Baccelli F, Colombini A, Contino A, Calore E, Petris MG, et al. Favorable outcome of SARS-CoV-2 infection in pediatric hematology oncology patients during the second and third pandemic waves in Italy: a multicenter analysis from the Infectious Diseases Working Group of the Associazione Italiana di Ematologia e Oncologia Pediatrica (AIEOP). Ann Hematol. 2022 Aug 1;101(8):1843–51.
TABLE 1. - Characteristics of SARS-CoV-2 infection in children without comorbidities and children with cancer. Descriptive analysis (mean (SD); N (%)) and p values obtained by Chi-Squared, Fisher, Mann-Whitney test or logistic regression. Only significant variables are shown.